Bifidice is the first gut microbiome biotech startup that created a technology stabilizing healthy bacterias to transform microbiota's composition. They applied this technology to frozen products and validated it in decreasing allergies and chronic diseases by up to 75%. By 2030, they expect to impact the health of 50 million people in the USA and the EU.